- Forbes•16 hours ago
Todd Hagopian recently identified five sub-sectors of Biotech poised for the best potential returns under President Trump. Today Todd gives us a deep dive into NASH (Nonalcoholic Steatohepatitis), the sub-sector that he is most excited about for 2017.
- Investopedia•19 hours ago
Safety concerns have re-emerged after a patient died in Roche’s hemophilia trial.
- Accesswire•21 hours agoBlog Coverage Novartis Gains Priority Review from the FDA for its Cancer Drug Zykadia as a Frontline Treatment for ALK-positive Non-Small Cell Lung Cancer
Upcoming AWS Coverage on Shire PLC Post-Earnings Results LONDON, UK / ACCESSWIRE / February 24, 2017 / Active Wall St. blog coverage looks at the headline from Novartis AG (NYSE: NVS ) as the Company announced ...
SHPG : Summary for Shire plc - Yahoo Finance
Shire plc (SHPG)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||180.80 x 300|
|Day's Range||180.31 - 183.86|
|52 Week Range||161.09 - 209.22|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||145.97|
|Dividend & Yield||0.80 (0.43%)|
|1y Target Est||N/A|